AMRX

SEC source: 0000899243-20-006627 · doc4.xml · derivative · entry 2

Branning Todd P. · CIK 0001765274 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,226

Underlying: Class A Common Stock · 166,226 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · shares: Represents the maximum number of shares issuable under the performance-based restricted stock units.

F5 · derivative.exercise_date: 25% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $8 or higher for 60 consecutive calendar days during the three-year performance period. An additional 12.5% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $10, $12, $14, $16, $18 and $20, respectively, for 60 consecutive calendar days during the three-year performance period. For average 60-day closing stock prices between $12 and $20 per share, the number of performance-based restricted stock units that become earned will be determined using straight line interpolation. Any earned performance-based restricted stock units vest in full on February 28, 2023, the last day of the performance period.

F5 · derivative.expiration_date: 25% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $8 or higher for 60 consecutive calendar days during the three-year performance period. An additional 12.5% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $10, $12, $14, $16, $18 and $20, respectively, for 60 consecutive calendar days during the three-year performance period. For average 60-day closing stock prices between $12 and $20 per share, the number of performance-based restricted stock units that become earned will be determined using straight line interpolation. Any earned performance-based restricted stock units vest in full on February 28, 2023, the last day of the performance period.

SEC source: 0000899243-20-006627 · doc4.xml · derivative · entry 1

Branning Todd P. · CIK 0001765274 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,113

Underlying: Class A Common Stock · 83,113 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning on February 27, 2021.

F2 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning on February 27, 2021.

SEC source: 0000899243-20-006625 · doc4.xml · derivative · entry 2

BOYER ANDREW S · CIK 0001239546 · Exec VP, Comm Optns

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253,298

Underlying: Class A Common Stock · 253,298 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · shares: Represents the maximum number of shares issuable under the performance-based restricted stock units.

F5 · derivative.exercise_date: 25% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $8 or higher for 60 consecutive calendar days during the three-year performance period. An additional 12.5% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $10, $12, $14, $16, $18 and $20, respectively, for 60 consecutive calendar days during the three-year performance period. For average 60-day closing stock prices between $12 and $20 per share, the number of performance-based restricted stock units that become earned will be determined using straight line interpolation. Any earned performance-based restricted stock units vest in full on February 28, 2023, the last day of the performance period.

F5 · derivative.expiration_date: 25% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $8 or higher for 60 consecutive calendar days during the three-year performance period. An additional 12.5% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $10, $12, $14, $16, $18 and $20, respectively, for 60 consecutive calendar days during the three-year performance period. For average 60-day closing stock prices between $12 and $20 per share, the number of performance-based restricted stock units that become earned will be determined using straight line interpolation. Any earned performance-based restricted stock units vest in full on February 28, 2023, the last day of the performance period.

SEC source: 0000899243-20-006625 · doc4.xml · derivative · entry 1

BOYER ANDREW S · CIK 0001239546 · Exec VP, Comm Optns

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,649

Underlying: Class A Common Stock · 126,649 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning on February 27, 2021.

F2 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning on February 27, 2021.

SEC source: 0001209191-20-004719 · doc4.xml · derivative · entry 3

Branning Todd P. · CIK 0001765274 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,290

Underlying: Class A Common Stock · 20,096 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · derivative.exercise_date: On January 22, 2019, the reporting person was granted 80,386 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date. The restricted stock units do not expire.

F4 · derivative.expiration_date: On January 22, 2019, the reporting person was granted 80,386 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date. The restricted stock units do not expire.

SEC source: 0001209191-20-004719 · doc4.xml · nonDerivative · entry 2

Branning Todd P. · CIK 0001765274 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,785

F3 · shares: Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.

SEC source: 0001209191-20-004719 · doc4.xml · nonDerivative · entry 1

Branning Todd P. · CIK 0001765274 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,096

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

SEC source: 0001723128-20-000002 · wf-form4_157834922391058.xml · derivative · entry 3

BUCHEN DAVID A · CIK 0001241751 · SVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,843

Underlying: Class A Common Stock · 27,614 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · derivative.exercise_date: On January 3, 2019, the reporting person was granted 110,457 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date. The restricted stock units do not expire.

F4 · derivative.expiration_date: On January 3, 2019, the reporting person was granted 110,457 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date. The restricted stock units do not expire.

SEC source: 0001723128-20-000002 · wf-form4_157834922391058.xml · nonDerivative · entry 2

BUCHEN DAVID A · CIK 0001241751 · SVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,426

F3 · shares: Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.

SEC source: 0001723128-20-000002 · wf-form4_157834922391058.xml · nonDerivative · entry 1

BUCHEN DAVID A · CIK 0001241751 · SVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,614

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

SEC source: 0001723128-19-000145 · wf-form4_157662264303996.xml · derivative · entry 2

George Jeffrey P. · CIK 0001796789 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,506

Underlying: Class A Common Stock · 28,506 shares

Expires 2029-12-14

F3 · derivative.exercise_date: The option vests on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.

SEC source: 0001723128-19-000145 · wf-form4_157662264303996.xml · derivative · entry 1

George Jeffrey P. · CIK 0001796789 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,522

Underlying: Class A Common Stock · 7,522 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · derivative.exercise_date: Restricted stock units vest on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. Restricted stock units have no expiration date.

F2 · derivative.expiration_date: Restricted stock units vest on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. Restricted stock units have no expiration date.

SEC source: 0001723128-19-000144 · wf-form4_157662262254101.xml · derivative · entry 2

Kiely John · CIK 0001781149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,522

Underlying: Class A Common Stock · 7,522 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: Restricted stock units vest on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. Restricted stock units have no expiration date.

F3 · derivative.expiration_date: Restricted stock units vest on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. Restricted stock units have no expiration date.

SEC source: 0001723128-19-000144 · wf-form4_157662262254101.xml · derivative · entry 1

Kiely John · CIK 0001781149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,506

Underlying: Class A Common Stock · 28,506 shares

Expires 2029-12-14

F1 · derivative.exercise_date: The option vests on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.

SEC source: 0001723128-19-000146 · wf-form4_157662266649783.xml · derivative · entry 2

Yanai Shlomo · CIK 0001562645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,522

Underlying: Class A Common Stock · 7,522 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: Restricted stock units vest on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. Restricted stock units have no expiration date.

F3 · derivative.expiration_date: Restricted stock units vest on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. Restricted stock units have no expiration date.

SEC source: 0001723128-19-000146 · wf-form4_157662266649783.xml · derivative · entry 1

Yanai Shlomo · CIK 0001562645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,506

Underlying: Class A Common Stock · 28,506 shares

Expires 2029-12-14

F1 · derivative.exercise_date: The option vests on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.

SEC source: 0001723128-19-000131 · wf-form4_157377043282006.xml · derivative · entry 4

Todisco Joseph · CIK 0001774807 · SVP, Specialty Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,498

Underlying: Class A Common Stock · 90,498 shares

Expires 2029-03-01

F2 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 1, 2019, and will vest in four equal annual installments beginning on March 1, 2020.

F2 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 1, 2019, and will vest in four equal annual installments beginning on March 1, 2020.

F2 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 1, 2019, and will vest in four equal annual installments beginning on March 1, 2020.

SEC source: 0001723128-19-000131 · wf-form4_157377043282006.xml · derivative · entry 3

Todisco Joseph · CIK 0001774807 · SVP, Specialty Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 90,498 shares

Expires 2029-03-01

F2 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 1, 2019, and will vest in four equal annual installments beginning on March 1, 2020.

F2 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 1, 2019, and will vest in four equal annual installments beginning on March 1, 2020.

F2 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 1, 2019, and will vest in four equal annual installments beginning on March 1, 2020.

SEC source: 0001723128-19-000131 · wf-form4_157377043282006.xml · derivative · entry 2

Todisco Joseph · CIK 0001774807 · SVP, Specialty Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,661

Underlying: Class A Common Stock · 72,661 shares

Expires 2028-05-07

F1 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on May 7, 2018, and vests in four equal annual installments beginning on May 7, 2019.

F1 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on May 7, 2018, and vests in four equal annual installments beginning on May 7, 2019.

F1 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on May 7, 2018, and vests in four equal annual installments beginning on May 7, 2019.

SEC source: 0001723128-19-000131 · wf-form4_157377043282006.xml · derivative · entry 1

Todisco Joseph · CIK 0001774807 · SVP, Specialty Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 72,661 shares

Expires 2028-05-07

F1 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on May 7, 2018, and vests in four equal annual installments beginning on May 7, 2019.

F1 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on May 7, 2018, and vests in four equal annual installments beginning on May 7, 2019.

F1 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on May 7, 2018, and vests in four equal annual installments beginning on May 7, 2019.

SEC source: 0001723128-19-000129 · wf-form4_157377039293557.xml · derivative · entry 2

Bhadauria Pradeep · CIK 0001774812 · SVP, Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,846

Underlying: Class A Common Stock · 153,846 shares

Expires 2029-04-15

F1 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on April 15, 2019, and will vest in four equal annual installments beginning on April 15, 2020.

F1 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on April 15, 2019, and will vest in four equal annual installments beginning on April 15, 2020.

F1 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on April 15, 2019, and will vest in four equal annual installments beginning on April 15, 2020.

SEC source: 0001723128-19-000129 · wf-form4_157377039293557.xml · derivative · entry 1

Bhadauria Pradeep · CIK 0001774812 · SVP, Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 153,846 shares

Expires 2029-04-15

F1 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on April 15, 2019, and will vest in four equal annual installments beginning on April 15, 2020.

F1 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on April 15, 2019, and will vest in four equal annual installments beginning on April 15, 2020.

F1 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on April 15, 2019, and will vest in four equal annual installments beginning on April 15, 2020.

SEC source: 0001723128-19-000130 · wf-form4_157377041302891.xml · derivative · entry 4

Shah Nikita · CIK 0001738061 · SVP, Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,525

Underlying: Class A Common Stock · 95,525 shares

Expires 2029-03-01

F2 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 1, 2019, and will vest in four equal annual installments beginning on March 1, 2020.

F2 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 1, 2019, and will vest in four equal annual installments beginning on March 1, 2020.

F2 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 1, 2019, and will vest in four equal annual installments beginning on March 1, 2020.

SEC source: 0001723128-19-000130 · wf-form4_157377041302891.xml · derivative · entry 3

Shah Nikita · CIK 0001738061 · SVP, Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 95,525 shares

Expires 2029-03-01

F2 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 1, 2019, and will vest in four equal annual installments beginning on March 1, 2020.

F2 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 1, 2019, and will vest in four equal annual installments beginning on March 1, 2020.

F2 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 1, 2019, and will vest in four equal annual installments beginning on March 1, 2020.

SEC source: 0001723128-19-000130 · wf-form4_157377041302891.xml · derivative · entry 2

Shah Nikita · CIK 0001738061 · SVP, Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,661

Underlying: Class A Common Stock · 72,661 shares

Expires 2028-05-07

F1 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on May 7, 2018, and vests in four equal annual installments beginning on May 7, 2019.

F1 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on May 7, 2018, and vests in four equal annual installments beginning on May 7, 2019.

F1 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on May 7, 2018, and vests in four equal annual installments beginning on May 7, 2019.

SEC source: 0001723128-19-000130 · wf-form4_157377041302891.xml · derivative · entry 1

Shah Nikita · CIK 0001738061 · SVP, Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 72,661 shares

Expires 2028-05-07

F1 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on May 7, 2018, and vests in four equal annual installments beginning on May 7, 2019.

F1 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on May 7, 2018, and vests in four equal annual installments beginning on May 7, 2019.

F1 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on May 7, 2018, and vests in four equal annual installments beginning on May 7, 2019.

SEC source: 0001723128-19-000128 · wf-form4_157377037285700.xml · derivative · entry 4

BOYER ANDREW S · CIK 0001239546 · Exec VP, Comm Optns

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,553

Underlying: Class A Common Stock · 100,553 shares

Expires 2029-03-01

F2 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 1, 2019, and will vest in four equal annual installments beginning on March 1, 2020.

F2 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 1, 2019, and will vest in four equal annual installments beginning on March 1, 2020.

F2 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 1, 2019, and will vest in four equal annual installments beginning on March 1, 2020.

SEC source: 0001723128-19-000128 · wf-form4_157377037285700.xml · derivative · entry 3

BOYER ANDREW S · CIK 0001239546 · Exec VP, Comm Optns

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 100,553 shares

Expires 2029-03-01

F2 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 1, 2019, and will vest in four equal annual installments beginning on March 1, 2020.

F2 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 1, 2019, and will vest in four equal annual installments beginning on March 1, 2020.

F2 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 1, 2019, and will vest in four equal annual installments beginning on March 1, 2020.

SEC source: 0001723128-19-000128 · wf-form4_157377037285700.xml · derivative · entry 2

BOYER ANDREW S · CIK 0001239546 · Exec VP, Comm Optns

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 272,480

Underlying: Class A Common Stock · 272,480 shares

Expires 2028-05-07

F1 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on May 7, 2018, and vests in four equal annual installments beginning on May 7, 2019.

F1 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on May 7, 2018, and vests in four equal annual installments beginning on May 7, 2019.

F1 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on May 7, 2018, and vests in four equal annual installments beginning on May 7, 2019.

SEC source: 0001723128-19-000128 · wf-form4_157377037285700.xml · derivative · entry 1

BOYER ANDREW S · CIK 0001239546 · Exec VP, Comm Optns

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 272,480 shares

Expires 2028-05-07

F1 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on May 7, 2018, and vests in four equal annual installments beginning on May 7, 2019.

F1 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on May 7, 2018, and vests in four equal annual installments beginning on May 7, 2019.

F1 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on May 7, 2018, and vests in four equal annual installments beginning on May 7, 2019.

SEC source: 0001723128-19-000127 · wf-form4_157377035410885.xml · derivative · entry 2

Branning Todd P. · CIK 0001765274 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 163,666

Underlying: Class A Common Stock · 163,666 shares

Expires 2029-01-22

F1 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on January 22, 2019, and will vest in four equal annual installments beginning on January 22, 2020.

F1 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on January 22, 2019, and will vest in four equal annual installments beginning on January 22, 2020.

F1 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on January 22, 2019, and will vest in four equal annual installments beginning on January 22, 2020.

SEC source: 0001723128-19-000127 · wf-form4_157377035410885.xml · derivative · entry 1

Branning Todd P. · CIK 0001765274 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 163,666 shares

Expires 2029-01-22

F1 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on January 22, 2019, and will vest in four equal annual installments beginning on January 22, 2020.

F1 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on January 22, 2019, and will vest in four equal annual installments beginning on January 22, 2020.

F1 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on January 22, 2019, and will vest in four equal annual installments beginning on January 22, 2020.

SEC source: 0001628280-19-013997 · wf-form4_157359524653914.xml · derivative · entry 4

Patel Gautam · CIK 0001738054 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 17,497,336

Underlying: Class A Common Stock · 12,887,433 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Common Units may be redeemed at any time for shares of the Issuer's Class A Common Stock on a 1-to-1 basis.

F3 · derivative.exercise_date: The Common Units may be redeemed at any time for shares of the Issuer's Class A Common Stock on a 1-to-1 basis.

F3 · derivative.expiration_date: The Common Units may be redeemed at any time for shares of the Issuer's Class A Common Stock on a 1-to-1 basis.

F1 · ownership.nature: By trusts which the reporting person may be deemed to control. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

SEC source: 0001628280-19-013997 · wf-form4_157359524653914.xml · nonDerivative · entry 2

Patel Gautam · CIK 0001738054 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 17,497,336

F2 · kind: Reflects the cancellation for no consideration of Class B Common Stock in connection with the conversion of the Common Units into shares of Class A Common Stock.

F1 · ownership.nature: By trusts which the reporting person may be deemed to control. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

SEC source: 0001628280-19-013997 · wf-form4_157359524653914.xml · nonDerivative · entry 1

Patel Gautam · CIK 0001738054 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 12,887,433

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: By trusts which the reporting person may be deemed to control. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

SEC source: 0001723128-19-000120 · wf-form4_156702560470079.xml · nonDerivative · entry 1

Nark Ted C · CIK 0001316851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,107

F1 · price: The price reported in column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $2.38 per share to $2.44 per share. The reporting person undertakes to provide Amneal Pharmaceuticals, Inc., any security holder of Amneal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001723128-19-000118 · wf-form4_156626296989842.xml · nonDerivative · entry 1

Bhadauria Pradeep · CIK 0001774812 · SVP, Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,500

F1 · price: The price reported in column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $2.40 per share to $2.43 per share. The reporting person undertakes to provide Amneal Pharmaceuticals, Inc., any security holder of Amneal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001723128-19-000116 · wf-form4_156520991278788.xml · nonDerivative · entry 1

BOYER ANDREW S · CIK 0001239546 · Exec VP, Comm Optns

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,968

F1 · price: The price reported in column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $2.86 per share to $2.92 per share. The reporting person undertakes to provide Amneal Pharmaceuticals, Inc., any security holder of Amneal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001144204-19-038365 · tv526990_form4.xml · nonDerivative · entry 1

Fosun International Ltd · CIK 0001447884 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · by Peak Reinsurance Company Limited

Disclosed balance after: 327,000

F1 · ownership.nature: Peak Reinsurance Company Limited is a subsidiary of the Reporting Person.

SEC source: 0001144204-19-038060 · tv526865_form4.xml · nonDerivative · entry 1

Fosun International Ltd · CIK 0001447884 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · by Fosun Atlas Capital SICAV RAIF S.C.S.

Disclosed balance after: 1,642,300

F1 · ownership.nature: Fosun Atlas Capital SICAV RAIF S.C.S. is a fund managed by a wholly-owned subsidiary of the Reporting Person.

SEC source: 0001723128-19-000114 · wf-form4_156512314716103.xml · derivative · entry 2

MEISTER PAUL M · CIK 0001033876 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,923

Underlying: Class A Common Stock · 27,923 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: Restricted stock units vest on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. Restricted stock units have no expiration date.

F3 · derivative.expiration_date: Restricted stock units vest on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. Restricted stock units have no expiration date.

SEC source: 0001723128-19-000114 · wf-form4_156512314716103.xml · derivative · entry 1

MEISTER PAUL M · CIK 0001033876 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,156

Underlying: Class A Common Stock · 115,156 shares

Expires 2029-08-02

F1 · derivative.exercise_date: The option vests on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.

SEC source: 0001723128-19-000097 · wf-form4_155804037951157.xml · nonDerivative · entry 1

Bhadauria Pradeep · CIK 0001774812 · SVP, Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

F1 · price: The price reported in column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $8.30 per share to $8.55 per share. The reporting person undertakes to provide Amneal Pharmaceuticals, Inc., any security holder of Amneal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001723128-19-000095 · wf-form4_155778284616883.xml · nonDerivative · entry 1

BOYER ANDREW S · CIK 0001239546 · Exec VP, Comm Optns

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,302

F1 · price: The price reported in column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $9.00 per share to $9.75 per share. The reporting person undertakes to provide Amneal Pharmaceuticals, Inc., any security holder of Amneal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001723128-19-000094 · wf-form4_155778282066089.xml · nonDerivative · entry 1

Todisco Joseph · CIK 0001774807 · SVP, Specialty Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 205,590

F1 · price: The price reported in column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $9.65 per share to $9.99 per share. The reporting person undertakes to provide Amneal Pharmaceuticals, Inc., any security holder of Amneal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001723128-19-000070 · wf-form4_155735207281386.xml · derivative · entry 4

Nark Ted C · CIK 0001316851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 6,107 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · derivative.exercise_date: On May 7, 2018, the reporting person was granted 6,107 restricted stock units vesting on May 8, 2019.

F4 · derivative.expiration_date: On May 7, 2018, the reporting person was granted 6,107 restricted stock units vesting on May 8, 2019.

SEC source: 0001723128-19-000070 · wf-form4_155735207281386.xml · nonDerivative · entry 1

Nark Ted C · CIK 0001316851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,107

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

SEC source: 0001723128-19-000068 · wf-form4_155735201312225.xml · derivative · entry 4

Vergis Janet S. · CIK 0001590794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 6,107 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · derivative.exercise_date: On May 7, 2018, the reporting person was granted 6,107 restricted stock units vesting on May 8, 2019.

F4 · derivative.expiration_date: On May 7, 2018, the reporting person was granted 6,107 restricted stock units vesting on May 8, 2019.

SEC source: 0001723128-19-000068 · wf-form4_155735201312225.xml · nonDerivative · entry 1

Vergis Janet S. · CIK 0001590794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,257

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

SEC source: 0001723128-19-000064 · wf-form4_155735188837195.xml · derivative · entry 4

Alva Emily Peterson · CIK 0001738422 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 6,107 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · derivative.exercise_date: On May 7, 2018, the reporting person was granted 6,107 restricted stock units vesting on May 8, 2019.

F4 · derivative.expiration_date: On May 7, 2018, the reporting person was granted 6,107 restricted stock units vesting on May 8, 2019.